Minocycline in Primary Sclerosing Cholangitis (PSC)

Pentoxifylline Treatment of Acute Pancreatitis

NCT01292005 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

NCT07091929 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

NCT01609140 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

NCT00185042 ·Status: COMPLETED ·Phase: PHASE2

Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)

NCT05739929 ·Status: UNKNOWN ·Phase: PHASE3

GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound

NCT01813422 ·Status: COMPLETED ·Phase: PHASE3

Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest

NCT03149406 ·Status: UNKNOWN

A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)

NCT01294709 ·Status: COMPLETED ·Phase: PHASE1

Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)

NCT00384293 ·Status: TERMINATED ·Phase: PHASE3

Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease

NCT06342609 ·Status: COMPLETED ·Phase: PHASE4

Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer

NCT05976893 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Effects of Paclitaxel on Intimal Hyperplasia

NCT01454778 ·Status: COMPLETED ·Phase: NA

Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients

NCT00995930 ·Status: COMPLETED ·Phase: PHASE2

A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients

NCT01499420 ·Status: COMPLETED ·Phase: PHASE2

Intra-arterial Prostaglandin Therapy in Non-occlusive Mesenteric Ischemia

NCT04235634 ·Status: COMPLETED

Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

NCT01666704 ·Status: WITHDRAWN ·Phase: PHASE2

Evaluation of Cilostazol in Combination With L-Carnitine

NCT00822172 ·Status: COMPLETED ·Phase: PHASE4

Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease

NCT03508609 ·Status: COMPLETED ·Phase: PHASE2

In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme

NCT06675994 ·Status: NOT_YET_RECRUITING

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

NCT04848220 ·Status: TERMINATED ·Phase: PHASE2

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

NCT02729025 ·Status: COMPLETED ·Phase: PHASE3

MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial

NCT02678923 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)

NCT03626662 ·Status: COMPLETED ·Phase: PHASE1

Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease

NCT03004638 ·Status: COMPLETED ·Phase: PHASE2

ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes

NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3